| [Download PDF]
|Year : 2009 | Volume
| Issue : 1 | Page : 19--22
Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats
Mamta Farswan1, Papiya Mitra Mazumder2, V Percha1,
1 Department of Pharmaceutical Sciences, SBS (PG) Institute of Biomedical Sciences, Balawala, Dehradun, India
2 Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
Department of Pharmaceutical Sciences, SBS (PG) Institute of Biomedical Sciences, Balawala, Dehradun
Objective: The objective of the present study was to investigate the hypoglycemic and hepatoprotective effect of Cassia glauca leaf extracts on normal and non insulin dependent diabetes mellitus (NIDDM) in rats. The study was further carried out to investigate the effect of different fractions of the active extract of Cassia glauca, on normal and NIDDM rats, and the effect of active fraction on the blood glucose and hepatic enzymes level.
Methods: Diabetes was induced by streptozotocin (STZ) at a dose of 90mg/kg, i.p. in neonates. Different extracts of cassia glauca (100mg/kg, p.o.) were administered to the diabetic rats. Acetone extract was found to lower the serum glucose level significantly in diabetic rats. Further, the acetone extract was subjected to column chromatography and four fractions were obtained on the basis of TLC. All the four fractions (100mg/kg, p.o.) were administered to the diabetic rats. Fraction 1 (F1) caused the maximum reduction in the blood glucose level. The results of the test were compared with the standard antidiabetic drug glibenclamide (5mg/kg, p.o.).
Results: Fraction 1 of acetone extract caused a significant reduction in the levels of hepatic enzyme Aspartate transaminase (AST), alanine transaminase (ALT), creatine kinase (CK), and lactate dehydrogenase (LDH) in STZ-induced diabetic rats.
Conclusion: Improvement in the blood sugar level and normalization of liver functions by Cassia glauca indicates that the plant has hepatoprotective potential, along with antidiabetic activity, and it provides a scientific rationale for the use of Cassia glauca as an antidiabetic agent.
|How to cite this article:|
Farswan M, Mazumder PM, Percha V. Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats.Indian J Pharmacol 2009;41:19-22
|How to cite this URL:|
Farswan M, Mazumder PM, Percha V. Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats. Indian J Pharmacol [serial online] 2009 [cited 2021 Jan 24 ];41:19-22
Available from: https://www.ijp-online.com/text.asp?2009/41/1/19/48887
There is still an unmet need for medicinal plants and phytopharmaceuticals with scientifically proven antidiabetic activity. Diabetes mellitus is characterized by a progressive decline in insulin action (insulin resistance, followed by the inability of β cells to compensate for insulin resistance.  The b cells normally compensate insulin resistance by secreting more amount of insulin to maintain the glucose homeostasis. In non insulin dependent diabetes mellitus (NIDDM) this β cell function gets impaired leading to deterioration in glucose homeostasis and subsequent development of impaired glucose tolerance and frank diabetes. , Hyperglycemia in the diabetics is associated with alteration of glucose and lipid metabolism and modification in liver enzymes level  .
Liver is an important insulin dependent tissue which plays a pivotal role in glucose and lipid metabolism and is severely affected during diabetes.  In diabetes the levels of hepatic enzymes increases. The level of ALT increases due to hepatocellular damage and is always accompanied by an increase in AST activity. Moreover the ALT and AST activity has been used as an indicator of liver function. 
The prevalence of diabetes is approximately 3% of the world population and is about 5% in the United States.  Approximately 10% of patients have type 1 diabetes mellitus (DM) and the remainder have type 2 Diabetes Mellitus.
Insulin and oral hypoglycemics are the most widely used drugs for diabetes but they also have various side effects like hypoglycemia, weight gain (sulfonylurea), lactic acidosis with biguinides and all of these drugs may cause liver and renal damage. 
From the beginning of last century, evidence of lipid lowering properties of medicinal plants has accumulated.  In recent years many traditionally used medicinal plants have been tested for their antidiabetic potential in experimental animals.  Ethnobotanical information indicates that more than 800 plants are used as traditional remedies for the treatment of diabetes. 
Cassia glauca (Family - Caesalpiniaceae) is about 10 ft high, evergreen shrub. Aerial parts of the plant are used as central nervous system depressant and as a diuretic.  Seeds of the plant are known to possess purgative and antimalarial properties. The leaves of the plant are pounded in sugar and milk and used to cure blennorrhagia. Bark and leaves are used in diabetes and gonorrhea in the folk lore medicine. This plant is also a good pollution tolerant and reduces chemical pollutants from the atmosphere.  Phytochemical investigation of the plant showed the presence of γ- sitosteroline, fatty acids, anthraquinones, tannins and alkaloids. The leaves contain β -sitosterol and lupeol . Different species of Cassia like Cassia alata ,  Cassia auriculata  have also been studied well for their antidiabetic potential. Therefore the objectives of the present study were to evaluate the hypoglycaemic and hepatoprotective activity of active fraction of Cassia glauca leaf extracts on normal and NIDDM rats. The results obtained with Cassia glauca were compared with glibenclamide, a commonly used hypoglycaemic agent.
Materials and Methods
Cassia glauca leaves were collected from the forest of Dehradun. The plant was identified, authenticated and the voucher specimen (A-30) has been kept at the herbarium of Sardar Bhagwan Singh (PG) Institute of Biomedical Sciences Dehradun. Streptozotocin was purchased from Calbiochem, Germany. Glibenclamide was obtained as gift samples from Ranbaxy Research Laboratories. Analytical grade chemicals like various organic solvents (petroleum ether, chloroform, acetone, and methanol) from E. Merck India Ltd and Ranbaxy were used for the extraction and phytochemical study of the constituents.
Preparation of Plant extracts
Fresh plant leaves were shade dried at room temperature, ground into fine powder, and then extracted (amount 450 gm) by solvents, petroleum ether, chloroform, acetone and methanol in increasing order of polarity of the solvents, for 24 h with each solvent by soxhlet extraction at a temperature of 60 0 C. After extraction the solvents were removed from the extracts (petroleum ether extract, chloroform extract, acetone extract and methanol extract of Cassia glauca leaf) under reduced pressure using a rotary evaporator. The extracts were collected and preserved in a desiccator until used for further studies.
All the extracts of the leaf of cassia glauca were screened for their phytoconstituents in order to see the chemical nature of the compounds present in the extracts. A portion of residue from each extract was subjected to phytochemical analysis in order to see the presence of sterols, alkaloids, carbohydrates, tannins, phenols etc in the extracts. ,
Fractionation of the acetone extract of Cassia glauca leaf
All the extracts of Cassia glauca leaf were screened for antidiabetic activity in diabetic rats. Acetone extract was found to show maximum reduction in blood sugar level, therefore attempts were made to isolate the active principle from the active acetone extract. The acetone extract (10 gm) was thus subjected to column chromatography using silica gel mesh (200-400) size and using CHCl 3 : MeOH in the increasing order of polarity as solvent. Based on thin layer chromatography (SiO 2 and CHCl 3 ) four fractions (F1, F2, F3, F4) were obtained from the active extract. These fractions were screened for antidiabetic activity. Fraction 1 showed maximum antidiabetic activity.
Determination of blood glucose and lipid profile in diabetic rats
Animals: Wistar albino rats of either sex were randomly bred in the Institutional animal house. The animals were housed in standard polypropylene cages and maintained under controlled room temperature(22 + 2 0 C) and humidity (55+5%) with 12:12 hour light and dark cycle. All the animals were provided with commercially available rat normal pellet diet and water ad libitum. The guidelines of committee for the purpose of control and supervision of experiments on animals (CPCSEA) Govt. of India were followed and prior approval was taken from the institutional animal ethics committee for conducting the animal experimental studies.
Acute toxicity studies
Acute toxicity studies were carried out on Swiss albino mice by the method of Ghosh.  Active acetone extract at a dose of 100, 300, 500, 1000 and 3000 mg/kg was administered to separate groups of mice each having 6 animals. After administration of extracts the animals were observed for first 3 hour for any toxic symptoms followed by observation at regular intervals for 24 hour up to 7 days. At the end of study the animals were also observed for general toxic signs, morphological behaviour and mortality. 
Induction of Diabetes
The method of Portha et. al was followed for the induction of diabetes. To induce type II diabetes, five day old Wistar neonates were injected intraperitonially with 90 mg/kg streptozotocin in 0.1M citrate buffer pH 4.5.  The control group received equivalent amount of citrate buffer. The pups were allowed to be with their respective mothers and weaned at 4 weeks of age. Eight weeks after injection of streptozotocin, the rats were checked for fasting blood sugar (FBS) level.  The animals showing FBS more than 150mg/dl were considered as diabetic and included for the study.
The diabetic animals were divided into five groups each having six animals. All the extracts were given at a dose of 100mg/kg, p.o., for a period of 15 days.
Group I: Normal animals received tween 80 in a dose of 1% suspension in distilled water.
Group II: Diabetic animals received tween 80 in a dose of 1% suspension in distilled water.
Group III: Diabetic animals received glibenclamide in a dose of 5 mg/kg, p.o.
Group IV: Diabetic animals received Petroleum ether extract in a dose of 100 mg/kg, p.o.
Group V: Diabetic animals received chloroform extract, in a dose of 100 mg/kg, p.o Group VI: Diabetic animals received acetone extract, in a dose of 100 mg/kg, p.o
Group VII: Diabetic animals received methanol extract. in a dose of 100 mg/kg, p.o.
At the end of experimental period the animals were fasted overnight and blood was taken from the retro orbital plexus under mild ether anesthesia, serum was separated out and blood sugar level was evaluated by the method of glucose oxidase- peroxides method using Span diagnostic kits.
Preliminary pharmacological screening of the fractions and effect of active fraction on hepatic enzymes level in diabetic rats
Diabetic animals were divided into five groups of five animals in each.
Group I: Normal animals received tween 80 in a dose of 1% suspension in distilled water.
Group II: Diabetic animals received tween 80 in a dose of 1% suspension in distilled water.
Group III: Diabetic animals received glibenclamide (5mg/kg),
Group IV- VII: diabetic animals received Fraction1 (F1) to fraction 4 (F4) respectively in a dose of 100mg/kg, p.o, for a period of 15 days.
At the end of experimental period animal were fasted overnight and blood was taken from the retro orbital plexus under mild ether anesthesia, it was centrifuged and serum was separated out. Effect of each fraction on FBS level was evaluated. Fraction 1 caused maximum reduction in FBS in diabetic rats. Serum from the group receiving fraction 1 was taken to study the effect of fraction 1 on the lipid profile. AST, ALT, CK and LDH were determined by UV kinetic method 22 using span diagnostic kits. Results of the test were compared with that of the standard antidiabetic drug glibenclamide.
The results were expressed as Mean + SEM. The unpaired t-test was used for analyzing the data between two groups. Statistical analysis of data was initially performed by using analysis of variance (ANOVA), when the overall ANOVA was significant, tukeys test for significance was applied to study the difference among the groups.
Petroleum ether extract of the leaf showed the presence of sterols. Chloroform extract showed the presence of carbohydrates & alkaloids. Acetone extract showed the presence of carbohydrates & alkaloids and tannins. Methanol showed the presence of tannins, and alkaloids. Water extract showed the presence of carbohydrates and glycosides.
Acute toxicity studies
Acute toxicity studies revealed that Cassia glauca extracts were practically non toxic when administered orally to mice. The LD50 value was 3gm/kg body weight.
Effect of Cassia glauca leaf extracts and Fractions of active extract on fasting blood sugar and hepatic enzymes level in diabetic rats.
[Table 1] illustrates the effect of different extracts of Cassia glauca on serum glucose level in the diabetic rats. Results showed that all the extracts caused reduction in blood glucose level but maximum reduction was found in acetone extract. Acetone extract showed 52% reduction as compared to glibenclamide (67%) reduction in fasting blood sugar. Acetone extract of the leaf caused significant (p Cassia glauca on serum glucose level in the diabetic rats. Results showed that all the fractions of acetone extract of the leaf caused significant decrease in the fasting blood glucose. However F1 exhibited maximum reduction in fasting blood sugar (59%) as compared to glibenclamide which caused 67% reduction in FBS.
[Table 3] illustrates the effect of F1 and glibenclamide on AST, ALT, Creatine kinase and lactate dehydrogenase level. Fraction 1 of the acetone extract caused significant (p  Administration of STZ caused rapid destruction of b cells which lead to a reduction of insulin release which slowly progress to impaired glucose stimulated insulin release and insulin resistance which are the marked feature of type II diabetes. The hypoglycemic effect of plant extracts is generally dependent upon the degree of b cell destruction. In diabetes, the increase in blood glucose level is usually accompanied by an increase in the activity of transaminases. More over the ALT, AST and LDH activities has been used as an indicator of liver function. Acetone extract caused significant reduction in the serum blood glucose level as compared to glibenclamide. Acetone extract was subjected to column chromatography in order to get fractions containing maximum hypoglycemic activity. Fraction 1 caused reduction in blood sugar which is more than the acetone extract. Fraction 1 also caused 31% reduction in the level of AST and 32% reduction in the level of ALT where as glibenclamide caused 23% reduction in the level of CK and 20% reduction in the level of LDH. The improvements in the levels of liver enzymes in diabetic animals could be beneficial in preventing diabetic complications, as well as improving lipid and protein metabolism in diabetic liver. The reversal of AST and ALT activity in Cassia glauca treated diabetic rats towards near normalcy is evidence of the prevention of cellular and tissue damage under diabetic conditions.
Phytochemical investigation of Cassia glauca leaf showed the presence of g-sitosteroline, fatty acids, anthraquinones, tannin and alkaloids. On the chemical basis it may be concluded that b - sitosterol and tannins in the leaf are responsible for the antidiabetic activity of Cassia glauca as it is known that tannins and sterols containing drugs possess antidiabetic activity. 
The present investigation revealed that acetone extract and fraction 1 of the acetone extract of Cassia glauca leaf has shown significant antidiabetic activity.
Improvement in the liver enzymes level by Cassia glauca indiates that the plant has hepatoprotective potential along with antidiabetic activity. The active constituent in the fraction responsible for antidiabetic and hepatoprotective activity is not known at present and work is on process to isolate it.
The authors are immensely thankful to management, SBS (PG) Institute of Biomedical Sciences and Research, Balawala Dehradun (U.K.) for providing the requisite facilities and financial support.
|1||Srinivasan K, Viswanad B, Asrat L, Kaul C L & Ramarao. Combination of high fat diet fed and low dose streptozotocin treated rats: A model for type II diabetes and pharmacological screening. Journal of Pharmacological Research 2005; 52: 313- 320.|
|2||Saltiel A R, Olefsky J M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45: 1661- 1669.|
|3||Banerji M A, Lebovitz H E. Treatment of insulin resistance in diabetes mellitus. Europian Journal of Pharmacology 2004; 490: 135- 46. |
|4||Jenson T, Stender, Deckert T. Abnormalities in plasma concentration of lipoprotein and fibrogen in type 1 (insulin dependent) diabetic patients with increased urinary albumin excretion. Diabetolgy 1998; 31: 142- 146.|
|5||Moller D. New drug targets for type 2 diabetes and the metabolic syndrome: A review. Nature 2001;414: 821-7 |
|6||Hearse DJ. Cellular damage during myocardial ischemia: Metabolic changes leading to enzyme leakage. In: hearse DS' Leiris j, Loisance D (eds). Enzymes in cardiology. John Wiley and Sons, Chichester. 1979; 1-21 |
|7||Sherwyn L, Schwartz. Diabetes and dyslipidaemias. Journal of diabetes, Obesity and Metabolism 2006; 8:355-364|
|8||Goodman and Gillman. The pharmacological basis of therapeutics. McGrow-Hill publication: 9 th edition 1996; 1508-1515. |
|9||Kritchevsky D. Dietary protein, cholesterol and atherosclerosis: A review of early history. J.Nutr 1995; 125(Suppl.3): 5589 - 93.|
|10||Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S. Beneficial effects of Aloe vera leaf gel extract on lipid profile status in rats with STZ diabetes. J Clinical and Experimental Pharmacology and Physiology 2006; 33: 232- 237.|
|11||Pushparay P, Tan C H, Tan B K H. Effect of Averrhoea bilimbi leaf extract on blood glucose and lipid in STZ- diabetic rats. J Ethnopharmacology 2000; 72: 69- 76. |
|12||Kirtikar K R, Basu B D. Indian medicinal plants. Vol I; 1988. p. 195- 196.|
|13||Warrier P K. Indian medicinal plants. Orient Logoum Ltd: Vol- 2. 2002. P. 3- 30. |
|14||Palanichamy S, Nagarajan S, Devasagayam M. Effect of Cassia auriculata on hyperglycemic rats. Journal of Ethnopharmacology 1998; 22: 81- 90.|
|15||Juvekar A R, Halade G V. Hypoglycemic activity of Cassia auriculata in neonatal streptozotocin induced non insulin dependent diabetes mellitus in rats. Journal of Natural Remedies 2006; 64: 14- 18.|
|16||Sofowora A. Medicinal plants and traditional medicines in Africa. John Wiley and Sons, Chichester; 1993. p. 256-57.|
|17||Wall M E, Eddy C R, McClenna M L, Klump M E. Detection and estimation of steroids and saponins in plant tissues. Anal Chem 1952; 24: 1337- 1342.|
|18||Ghosh M N. Toxicity studies in Fundamentals of experimental pharmacology. Hilton and Company, Kolkata: 2005. p. 190-197. |
|19||Dhar M L, Dhar M M, Dhawan B N, Melhotra B N, Ray C. Screening of Indian plants for biological activity. Indian Journal of Experimental Biology 1968; 232-247. |
|20||Portha B, Kerogoat M, Blondel O, Bailbe D. The rat models of NIDDM by neonatal streptozotocin. Diabetes and Metabolism 1989; 15: 61- 75.|
|21||Fantus I G, Chayoth R O, Dea L, Marlis M B, Yale J F, Grose M. Insulin binding and glucose transport in adipocytes in neonatal streptozocin-injected rat model of diabetes mellitus. Diabetes 1987; 36: 654-660.|
|22||King J. The transferase alanine and transaminase. In: van D (ed.). Practical clinical enzymology. Nostrand, London. 1965; 363-75.|
|23||Shukla R, Sharma S B, Puri D, Prabhu K M, Murthy P S. Indian Journal of Clinical Biochem 2002; 15: 167-177. |
|24||Hatapakki B C, Suresh H M, Bhoomannavar V, Shivkumar S I. Effect of Cassia auriculata Linn. flowers against alloxan induced diabetes in rats. Journal of Natural Remedies 2005; 5/2: 132- 136.|